Topic: Side Effects

Users of GLP-1 weight loss drugs are reporting significant side effects, including hair loss, muscle atrophy, and "ozempic face." The hair treatment industry is reportedly seeing a billion-dollar opportunity as a result of these complications. The segment warns that the aesthetic benefits of rapid weight loss are often offset by these systemic health issues.

Ozempic is facing over 2,000 lawsuits alleging that the manufacturer downplayed severe side effects, including blindness and intestinal issues. Legal experts are now calculating damages for physical harm, emotional distress, and lost wages for affected users.

The hosts review increasingly alarming drug disclaimers for medications like Zepbound and Camzyos. Side effects listed include suicidal thoughts, heart failure, and death, which the hosts contrast with older, less severe pharmaceutical warnings.

A TikTok creator shared her experience of becoming bedridden for a week following COVID-19 and flu vaccinations. Despite her history of severe reactions, she continues to follow the vaccination schedule and requests "good vibes" from her audience. The segment highlights the culture of public health virtue signaling and the use of Tylenol to manage vaccine-induced illness.

A new executive order aims to reinstate 1997-era rules requiring pharmaceutical companies to list all side effects in television advertisements. The hosts suggest this move will result in much longer commercials, potentially benefiting cable news revenue in the short term while discouraging drug companies from advertising due to the negative impact of long side-effect lists.

The discussion revisits the 1990s launch of Olestra, a fat substitute used in Frito-Lay's "WOW" potato chips. The product was notorious for causing digestive issues and leaving a waxy coating on the palate. The anecdote serves as a cautionary tale regarding the public's historical skepticism of lab-engineered food substitutes.

Donald Trump claimed he would reduce prescription drug prices by unprecedented percentages, ranging from 500% to 1,500%. The statement drew comparisons to pharmaceutical advertisements for drugs like Jardiance, which list severe side effects including rare infections. Critics question the mathematical feasibility of price drops exceeding 100%.

Robert F. Kennedy Jr. has proposed restricting pharmaceutical advertising on television, a move that could significantly impact news network revenue. Before 1997, FDA regulations required companies to list all side effects in detail, which made broadcast ads prohibitively expensive. A return to these stricter disclosure rules would likely reduce the volume of direct-to-consumer drug marketing.

Listeners send in donations in honor of their fathers, with some sharing sobering stories of loss and health struggles. One donor, Amzie Meyer, requests prayers for those suffering from medical complications allegedly linked to recent vaccinations. Another tribute comes from Sir Donald in Calgary, who honors his late father and seeks "house hunting karma" as he relocates within Alberta. The segment blends personal memorials with broader social commentary.

The New York Post reported on a new claimed side effect of the weight loss drug Ozempic, where male users suggest their penises appear larger after significant weight loss. The phenomenon is attributed to the reduction of abdominal fat rather than actual growth of the organ. The hosts express skepticism and mock the sensationalist nature of the reporting.

In an interview on Gary Brekka's podcast, Robert F. Kennedy Jr. discussed the legal challenges of banning direct-to-consumer pharmaceutical advertising due to First Amendment protections. He argued that taxpayers effectively subsidize these ads because the government pays for the resulting drug prescriptions through federal agencies. The segment highlights the extensive side effects listed in drug commercials, such as those for the bone drug Evenity.

Scott Adams has questioned the medical consensus regarding the progression of his and Joe Biden's prostate cancer, suggesting the disease is moving at an unnaturally rapid pace. The term "turbo cancer" is discussed in relation to the COVID-19 vaccine's potential impact on reproductive organs and the immune system. Adams' skepticism toward his doctors' timelines suggests he believes an external factor accelerated the stage 4 metastasis.

A lawsuit in New Jersey alleges that the weight-loss drug Ozempic caused a woman to go blind by inducing a condition called NION. Reports are also surfacing of "Ozempic feet," a side effect where toes curl permanently, allegedly observed in celebrities like Sharon Osbourne. The discussion highlights the lack of transparency from Novo Nordisk and the aggressive marketing efforts to classify obesity as a disease to secure insurance coverage for the drug.

Early data from Moderna's vaccine trials showed that 80% of participants experienced systemic side effects like chills and fevers after the second dose. Experts noted that most leading vaccine candidates would require two doses, creating a massive logistical challenge for manufacturing and public compliance. Ensuring that elderly populations are well-represented in trials was identified as a priority for gathering accurate safety data.

An analysis of a television advertisement for the heartburn medication Voquezna reveals a long list of severe potential side effects, including bone fractures, seizures, and kidney problems. The hosts question the logic of pharmaceutical advertising that encourages patients to risk major health complications for minor ailments.

A new study has linked popular weight loss drugs Ozempic and Wegovy to a rare form of blindness known as NAION (non-arteritic anterior ischemic optic neuropathy). The condition, described as an "eye stroke," causes sudden and painless vision loss due to restricted blood flow to the optic nerve. Diabetic patients taking semaglutide were found to be four times more likely to develop the condition than those not on the medication.

ABC News medical correspondent Dr. Jen Ashton discussed the safety profile of GLP-1 drugs, noting they have been FDA-approved for type 2 diabetes for nearly 20 years. While the segment downplayed risks like pancreatitis and thyroid cancer as rare, critics pointed out that a 1% risk rate is significant when applied to millions of users. The discussion highlighted the lack of long-term human studies on the effects of these drugs when used specifically for weight loss in non-diabetic populations.

Listeners shared accounts of being prescribed antidepressants like amitriptyline for pain management without being informed of the drug's primary use. A psychiatric nurse reported on the known side effects of impulsive behavior and violence associated with the first three weeks of starting medications like Prozac or Paxil.

A Bloomberg medical report suggests that COVID-19 infections are linked to increases in diabetes, stroke, and Alzheimer's. The reporter acknowledged that vaccines caused "some harm" but maintained that the benefits of lives saved outweighed the risks of side effects.

Dame Mamakon contributed $500 and shared a warning about vaccine-related health issues, citing the Pfizer clinical trial side effects list. Other major donations came from Blaine in Houston and Chap Williams, while Scott from Sioux Rapids became an executive producer for his 66th birthday.